Literature DB >> 22971062

The COPD Assessment Test in the evaluation of chronic obstructive pulmonary disease exacerbations.

Alfredo Chetta1, Dario Olivieri.   

Abstract

Evaluation of: Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am. J. Respir. Crit. Care Med. 185(11), 1218-1224 (2012). The health status of patients with chronic obstructive pulmonary disease (COPD) is currently being assessed using several different questionnaires. One of them is the COPD Assessment Test (CAT), which is a quick and easy test for patients to complete and provides a score that indicates the impact of the disease on their health status. There is increasing evidence that the CAT is a promising tool to quantify COPD exacerbations. Accordingly, the CAT score can be a useful marker in clinical trials that evaluate the effectiveness of treatments in prevention or management of COPD exacerbations, or that investigate the disease progression over time. In the future, the CAT score could also be used as an outcome measure in clinical practice to track changes in patients' overall health status and to improve communication between patients and healthcare professionals.

Entities:  

Year:  2012        PMID: 22971062     DOI: 10.1586/ers.12.37

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  6 in total

1.  Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients.

Authors:  Juliana Ruiz Fernandes; Cibele Cristine Berto Marques da Silva; Aline Grandi da Silva; Regina Maria de Carvalho Pinto; Alberto José da Silva Duarte; Celso Ricardo Carvalho; Gil Benard
Journal:  Lung       Date:  2018-03-10       Impact factor: 2.584

2.  Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

3.  Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm.

Authors:  Kirill A Zykov; Svetlana I Ovcharenko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-11

4.  The role of CAT in evaluating the response to treatment of patients with AECOPD.

Authors:  Aiyuan Zhou; Zijing Zhou; Yating Peng; Yiyang Zhao; Jiaxi Duan; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-11

5.  The COPD (Chronic Obstructive Pulmonary Disease) Assessment Test: Assessment of Therapeutic Outcomes of Patients at Private Hospitals in Yogyakarta.

Authors:  Chynthia Pradiftha Sari; Suci Hanifah; Rosdiana Rosdiana; Yuni Anisa
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

6.  Evaluation of the Persian Transcript of the COPD Assessment Test in the Measurement of COPD Health Status in Iranian COPD Patients.

Authors:  Alireza Azargon; Mohammadreza Gholami; Ali Farhadi; Maryam Hadi Chegni; Abolfazl Zendedel
Journal:  Glob J Health Sci       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.